Belgian molecular Dx company obtains $7.3 million

02/15/2013 | GenomeWeb Daily News (free registration)

A funding round has pulled in $7.3 million for Multiplicom, a Belgian firm that develops research-use-only test kits for muscle disease, cystic fibrosis, kidney disease, heart failure and bowel cancer. The company will use the money to further develop its molecular diagnostic tests and expand its sales channels in Europe.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Confidential
Pompano Beach, FL